Sebastian, A.; Madej, M.; Gajdanowicz, P.; Sebastian, M.; Łuczak, A.; Zemelka-Wiącek, M.; Jutel, M.; Wiland, P.
Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren’s Syndrome? J. Clin. Med. 2022, 11, 5405.
https://doi.org/10.3390/jcm11185405
AMA Style
Sebastian A, Madej M, Gajdanowicz P, Sebastian M, Łuczak A, Zemelka-Wiącek M, Jutel M, Wiland P.
Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren’s Syndrome? Journal of Clinical Medicine. 2022; 11(18):5405.
https://doi.org/10.3390/jcm11185405
Chicago/Turabian Style
Sebastian, Agata, Marta Madej, Paweł Gajdanowicz, Maciej Sebastian, Anna Łuczak, Magdalena Zemelka-Wiącek, Marek Jutel, and Piotr Wiland.
2022. "Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren’s Syndrome?" Journal of Clinical Medicine 11, no. 18: 5405.
https://doi.org/10.3390/jcm11185405
APA Style
Sebastian, A., Madej, M., Gajdanowicz, P., Sebastian, M., Łuczak, A., Zemelka-Wiącek, M., Jutel, M., & Wiland, P.
(2022). Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren’s Syndrome? Journal of Clinical Medicine, 11(18), 5405.
https://doi.org/10.3390/jcm11185405